nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0919	0.134	CbGbCtD
Ezetimibe—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0498	0.0726	CbGbCtD
Ezetimibe—ABCC3—Lamivudine—acquired immunodeficiency syndrome	0.0445	0.065	CbGbCtD
Ezetimibe—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0354	0.0516	CbGbCtD
Ezetimibe—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0344	0.0501	CbGbCtD
Ezetimibe—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.0311	0.0453	CbGbCtD
Ezetimibe—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0311	0.0453	CbGbCtD
Ezetimibe—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0311	0.0453	CbGbCtD
Ezetimibe—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0273	0.0398	CbGbCtD
Ezetimibe—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0273	0.0398	CbGbCtD
Ezetimibe—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0273	0.0398	CbGbCtD
Ezetimibe—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0247	0.036	CbGbCtD
Ezetimibe—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0247	0.036	CbGbCtD
Ezetimibe—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0237	0.0345	CbGbCtD
Ezetimibe—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0202	0.0295	CbGbCtD
Ezetimibe—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0183	0.0267	CbGbCtD
Ezetimibe—ANPEP—Metabolism of Angiotensinogen to Angiotensins—ENPEP—acquired immunodeficiency syndrome	0.0141	0.442	CbGpPWpGaD
Ezetimibe—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.013	0.0189	CbGbCtD
Ezetimibe—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0117	0.0171	CbGbCtD
Ezetimibe—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0101	0.0148	CbGbCtD
Ezetimibe—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00984	0.0143	CbGbCtD
Ezetimibe—ABCG5—blood plasma—acquired immunodeficiency syndrome	0.00954	0.123	CbGeAlD
Ezetimibe—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0089	0.013	CbGbCtD
Ezetimibe—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0089	0.013	CbGbCtD
Ezetimibe—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00853	0.0124	CbGbCtD
Ezetimibe—ABCG8—blood plasma—acquired immunodeficiency syndrome	0.0085	0.11	CbGeAlD
Ezetimibe—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00827	0.0121	CbGbCtD
Ezetimibe—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00778	0.0113	CbGbCtD
Ezetimibe—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00778	0.0113	CbGbCtD
Ezetimibe—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00704	0.0103	CbGbCtD
Ezetimibe—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00704	0.0103	CbGbCtD
Ezetimibe—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0066	0.00962	CbGbCtD
Ezetimibe—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00607	0.00885	CbGbCtD
Ezetimibe—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0059	0.0086	CbGbCtD
Ezetimibe—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00533	0.00777	CbGbCtD
Ezetimibe—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00533	0.00777	CbGbCtD
Ezetimibe—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00511	0.00745	CbGbCtD
Ezetimibe—ANPEP—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00372	0.116	CbGpPWpGaD
Ezetimibe—ABCG5—digestive system—acquired immunodeficiency syndrome	0.00367	0.0472	CbGeAlD
Ezetimibe—NPC1L1—digestive system—acquired immunodeficiency syndrome	0.00345	0.0444	CbGeAlD
Ezetimibe—NPC1L1—blood—acquired immunodeficiency syndrome	0.00329	0.0423	CbGeAlD
Ezetimibe—ABCG8—digestive system—acquired immunodeficiency syndrome	0.00327	0.0421	CbGeAlD
Ezetimibe—ABCG8—blood—acquired immunodeficiency syndrome	0.00311	0.0401	CbGeAlD
Ezetimibe—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00185	0.0239	CbGeAlD
Ezetimibe—SOAT1—retina—acquired immunodeficiency syndrome	0.00168	0.0217	CbGeAlD
Ezetimibe—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00154	0.0199	CbGeAlD
Ezetimibe—ABCC3—blood plasma—acquired immunodeficiency syndrome	0.00146	0.0189	CbGeAlD
Ezetimibe—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00146	0.0188	CbGeAlD
Ezetimibe—ANPEP—skin of body—acquired immunodeficiency syndrome	0.00141	0.0182	CbGeAlD
Ezetimibe—UGT2B15—digestive system—acquired immunodeficiency syndrome	0.00137	0.0177	CbGeAlD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—CXCR4—acquired immunodeficiency syndrome	0.00131	0.0409	CbGpPWpGaD
Ezetimibe—SOAT1—digestive system—acquired immunodeficiency syndrome	0.00118	0.0152	CbGeAlD
Ezetimibe—ANPEP—lymphoid tissue—acquired immunodeficiency syndrome	0.00114	0.0147	CbGeAlD
Ezetimibe—ANPEP—digestive system—acquired immunodeficiency syndrome	0.00113	0.0145	CbGeAlD
Ezetimibe—SOAT1—blood—acquired immunodeficiency syndrome	0.00113	0.0145	CbGeAlD
Ezetimibe—SOAT1—bone marrow—acquired immunodeficiency syndrome	0.00109	0.014	CbGeAlD
Ezetimibe—SOAT1—spinal cord—acquired immunodeficiency syndrome	0.00108	0.014	CbGeAlD
Ezetimibe—ANPEP—blood—acquired immunodeficiency syndrome	0.00108	0.0139	CbGeAlD
Ezetimibe—SOAT1—vagina—acquired immunodeficiency syndrome	0.00104	0.0134	CbGeAlD
Ezetimibe—ANPEP—bone marrow—acquired immunodeficiency syndrome	0.00104	0.0134	CbGeAlD
Ezetimibe—ANPEP—vagina—acquired immunodeficiency syndrome	0.000997	0.0128	CbGeAlD
Ezetimibe—SOAT1—lung—acquired immunodeficiency syndrome	0.000986	0.0127	CbGeAlD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—ALB—acquired immunodeficiency syndrome	0.00095	0.0297	CbGpPWpGaD
Ezetimibe—ANPEP—lung—acquired immunodeficiency syndrome	0.000943	0.0122	CbGeAlD
Ezetimibe—SOAT1—nervous system—acquired immunodeficiency syndrome	0.000913	0.0118	CbGeAlD
Ezetimibe—SOAT1—central nervous system—acquired immunodeficiency syndrome	0.000879	0.0113	CbGeAlD
Ezetimibe—ANPEP—nervous system—acquired immunodeficiency syndrome	0.000874	0.0113	CbGeAlD
Ezetimibe—ANPEP—central nervous system—acquired immunodeficiency syndrome	0.000841	0.0108	CbGeAlD
Ezetimibe—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.000839	0.0108	CbGeAlD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—ALB—acquired immunodeficiency syndrome	0.00072	0.0225	CbGpPWpGaD
Ezetimibe—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000713	0.00918	CbGeAlD
Ezetimibe—ANPEP—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000702	0.0219	CbGpPWpGaD
Ezetimibe—SOAT1—brain—acquired immunodeficiency syndrome	0.000698	0.00899	CbGeAlD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—ALB—acquired immunodeficiency syndrome	0.000693	0.0217	CbGpPWpGaD
Ezetimibe—UGT1A1—blood—acquired immunodeficiency syndrome	0.000679	0.00875	CbGeAlD
Ezetimibe—SOAT1—lymph node—acquired immunodeficiency syndrome	0.000675	0.00869	CbGeAlD
Ezetimibe—ANPEP—brain—acquired immunodeficiency syndrome	0.000668	0.0086	CbGeAlD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000662	0.0207	CbGpPWpGaD
Ezetimibe—ANPEP—lymph node—acquired immunodeficiency syndrome	0.000645	0.00831	CbGeAlD
Ezetimibe—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000594	0.00765	CbGeAlD
Ezetimibe—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000593	0.00764	CbGeAlD
Ezetimibe—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000565	0.00728	CbGeAlD
Ezetimibe—ABCC3—digestive system—acquired immunodeficiency syndrome	0.000563	0.00725	CbGeAlD
Ezetimibe—ABCC3—blood—acquired immunodeficiency syndrome	0.000536	0.00691	CbGeAlD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000502	0.0157	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000483	0.0151	CbGpPWpGaD
Ezetimibe—ABCC3—lung—acquired immunodeficiency syndrome	0.00047	0.00606	CbGeAlD
Ezetimibe—SLCO1B1—Transport of organic anions—ALB—acquired immunodeficiency syndrome	0.000462	0.0144	CbGpPWpGaD
Ezetimibe—ABCC3—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.00046	0.0144	CbGpPWpGaD
Ezetimibe—ABCC2—digestive system—acquired immunodeficiency syndrome	0.00045	0.00579	CbGeAlD
Ezetimibe—ABCC3—nervous system—acquired immunodeficiency syndrome	0.000435	0.00561	CbGeAlD
Ezetimibe—ABCC2—blood—acquired immunodeficiency syndrome	0.000429	0.00552	CbGeAlD
Ezetimibe—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000421	0.00542	CbGeAlD
Ezetimibe—ABCC3—central nervous system—acquired immunodeficiency syndrome	0.000419	0.0054	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.00039	0.0122	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000347	0.0108	CbGpPWpGaD
Ezetimibe—SLCO1B1—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.000342	0.0107	CbGpPWpGaD
Ezetimibe—ABCC3—brain—acquired immunodeficiency syndrome	0.000333	0.00429	CbGeAlD
Ezetimibe—ABCC3—lymph node—acquired immunodeficiency syndrome	0.000322	0.00414	CbGeAlD
Ezetimibe—ABCG2—blood—acquired immunodeficiency syndrome	0.000313	0.00403	CbGeAlD
Ezetimibe—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000302	0.0039	CbGeAlD
Ezetimibe—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000301	0.00388	CbGeAlD
Ezetimibe—NPC1L1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000295	0.00922	CbGpPWpGaD
Ezetimibe—ABCG2—vagina—acquired immunodeficiency syndrome	0.00029	0.00373	CbGeAlD
Ezetimibe—ABCG2—lung—acquired immunodeficiency syndrome	0.000274	0.00353	CbGeAlD
Ezetimibe—ABCG8—Metabolism—TAT—acquired immunodeficiency syndrome	0.000263	0.00822	CbGpPWpGaD
Ezetimibe—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000257	0.00331	CbGeAlD
Ezetimibe—ABCG5—Metabolism—TAT—acquired immunodeficiency syndrome	0.000253	0.00791	CbGpPWpGaD
Ezetimibe—ABCC3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.00024	0.00751	CbGpPWpGaD
Ezetimibe—ABCB1—retina—acquired immunodeficiency syndrome	0.00023	0.00297	CbGeAlD
Ezetimibe—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000229	0.00294	CbGeAlD
Ezetimibe—ABCG8—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000223	0.00699	CbGpPWpGaD
Ezetimibe—CYP3A4—blood—acquired immunodeficiency syndrome	0.000218	0.0028	CbGeAlD
Ezetimibe—ABCG5—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000215	0.00673	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000212	0.00663	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000209	0.00653	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000209	0.00653	CbGpPWpGaD
Ezetimibe—ABCG2—brain—acquired immunodeficiency syndrome	0.000194	0.0025	CbGeAlD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000188	0.00589	CbGpPWpGaD
Ezetimibe—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000187	0.00241	CbGeAlD
Ezetimibe—SLCO1B1—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.000179	0.00559	CbGpPWpGaD
Ezetimibe—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000177	0.00228	CbGeAlD
Ezetimibe—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000171	0.00536	CbGpPWpGaD
Ezetimibe—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00017	0.00219	CbGeAlD
Ezetimibe—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000164	0.00211	CbGeAlD
Ezetimibe—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000162	0.00208	CbGeAlD
Ezetimibe—ABCB1—blood—acquired immunodeficiency syndrome	0.000154	0.00198	CbGeAlD
Ezetimibe—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00015	0.000736	CcSEcCtD
Ezetimibe—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000735	CcSEcCtD
Ezetimibe—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000735	CcSEcCtD
Ezetimibe—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000734	CcSEcCtD
Ezetimibe—Rash—Didanosine—acquired immunodeficiency syndrome	0.000149	0.00073	CcSEcCtD
Ezetimibe—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000729	CcSEcCtD
Ezetimibe—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000729	CcSEcCtD
Ezetimibe—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000149	0.000729	CcSEcCtD
Ezetimibe—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000149	0.00192	CbGeAlD
Ezetimibe—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000149	0.000729	CcSEcCtD
Ezetimibe—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000148	0.00191	CbGeAlD
Ezetimibe—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000726	CcSEcCtD
Ezetimibe—Headache—Didanosine—acquired immunodeficiency syndrome	0.000148	0.000725	CcSEcCtD
Ezetimibe—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000724	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—TAT—acquired immunodeficiency syndrome	0.000148	0.00463	CbGpPWpGaD
Ezetimibe—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000148	0.000723	CcSEcCtD
Ezetimibe—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000722	CcSEcCtD
Ezetimibe—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000147	0.000721	CcSEcCtD
Ezetimibe—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.00072	CcSEcCtD
Ezetimibe—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000719	CcSEcCtD
Ezetimibe—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000718	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000146	0.00458	CbGpPWpGaD
Ezetimibe—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000715	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000714	CcSEcCtD
Ezetimibe—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000713	CcSEcCtD
Ezetimibe—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000713	CcSEcCtD
Ezetimibe—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000146	0.000712	CcSEcCtD
Ezetimibe—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000145	0.000711	CcSEcCtD
Ezetimibe—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000145	0.00071	CcSEcCtD
Ezetimibe—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000709	CcSEcCtD
Ezetimibe—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000708	CcSEcCtD
Ezetimibe—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000708	CcSEcCtD
Ezetimibe—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000708	CcSEcCtD
Ezetimibe—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000706	CcSEcCtD
Ezetimibe—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000706	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000703	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000701	CcSEcCtD
Ezetimibe—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000143	0.0007	CcSEcCtD
Ezetimibe—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000143	0.0007	CcSEcCtD
Ezetimibe—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.0007	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000699	CcSEcCtD
Ezetimibe—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000699	CcSEcCtD
Ezetimibe—ABCB1—vagina—acquired immunodeficiency syndrome	0.000143	0.00184	CbGeAlD
Ezetimibe—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000698	CcSEcCtD
Ezetimibe—Pain—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000695	CcSEcCtD
Ezetimibe—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000695	CcSEcCtD
Ezetimibe—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000694	CcSEcCtD
Ezetimibe—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000694	CcSEcCtD
Ezetimibe—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000693	CcSEcCtD
Ezetimibe—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000691	CcSEcCtD
Ezetimibe—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.00069	CcSEcCtD
Ezetimibe—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.00069	CcSEcCtD
Ezetimibe—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.00069	CcSEcCtD
Ezetimibe—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000689	CcSEcCtD
Ezetimibe—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000689	CcSEcCtD
Ezetimibe—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000141	0.000687	CcSEcCtD
Ezetimibe—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000141	0.000687	CcSEcCtD
Ezetimibe—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000685	CcSEcCtD
Ezetimibe—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000684	CcSEcCtD
Ezetimibe—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000682	CcSEcCtD
Ezetimibe—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000682	CcSEcCtD
Ezetimibe—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000682	CcSEcCtD
Ezetimibe—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000138	0.000677	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000677	CcSEcCtD
Ezetimibe—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000675	CcSEcCtD
Ezetimibe—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000674	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000137	0.00429	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000669	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000669	CcSEcCtD
Ezetimibe—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000667	CcSEcCtD
Ezetimibe—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000667	CcSEcCtD
Ezetimibe—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000667	CcSEcCtD
Ezetimibe—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.000666	CcSEcCtD
Ezetimibe—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000666	CcSEcCtD
Ezetimibe—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000665	CcSEcCtD
Ezetimibe—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000136	0.000664	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000664	CcSEcCtD
Ezetimibe—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000664	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000136	0.00425	CbGpPWpGaD
Ezetimibe—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000662	CcSEcCtD
Ezetimibe—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000135	0.000662	CcSEcCtD
Ezetimibe—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000662	CcSEcCtD
Ezetimibe—ABCB1—lung—acquired immunodeficiency syndrome	0.000135	0.00174	CbGeAlD
Ezetimibe—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000659	CcSEcCtD
Ezetimibe—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000659	CcSEcCtD
Ezetimibe—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000659	CcSEcCtD
Ezetimibe—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000656	CcSEcCtD
Ezetimibe—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000656	CcSEcCtD
Ezetimibe—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000656	CcSEcCtD
Ezetimibe—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000134	0.000656	CcSEcCtD
Ezetimibe—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000655	CcSEcCtD
Ezetimibe—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000134	0.000655	CcSEcCtD
Ezetimibe—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.000652	CcSEcCtD
Ezetimibe—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00065	CcSEcCtD
Ezetimibe—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00065	CcSEcCtD
Ezetimibe—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00065	CcSEcCtD
Ezetimibe—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000649	CcSEcCtD
Ezetimibe—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000646	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000646	CcSEcCtD
Ezetimibe—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000645	CcSEcCtD
Ezetimibe—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000643	CcSEcCtD
Ezetimibe—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000642	CcSEcCtD
Ezetimibe—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000642	CcSEcCtD
Ezetimibe—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000641	CcSEcCtD
Ezetimibe—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000131	0.000641	CcSEcCtD
Ezetimibe—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00064	CcSEcCtD
Ezetimibe—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000131	0.000639	CcSEcCtD
Ezetimibe—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000638	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.00013	0.00407	CbGpPWpGaD
Ezetimibe—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000636	CcSEcCtD
Ezetimibe—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.000635	CcSEcCtD
Ezetimibe—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00013	0.000635	CcSEcCtD
Ezetimibe—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000635	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000634	CcSEcCtD
Ezetimibe—Rash—Stavudine—acquired immunodeficiency syndrome	0.00013	0.000634	CcSEcCtD
Ezetimibe—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000633	CcSEcCtD
Ezetimibe—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000633	CcSEcCtD
Ezetimibe—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000632	CcSEcCtD
Ezetimibe—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000631	CcSEcCtD
Ezetimibe—Headache—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000629	CcSEcCtD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000129	0.00403	CbGpPWpGaD
Ezetimibe—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000129	0.000629	CcSEcCtD
Ezetimibe—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000629	CcSEcCtD
Ezetimibe—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000628	CcSEcCtD
Ezetimibe—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000628	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000627	CcSEcCtD
Ezetimibe—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000627	CcSEcCtD
Ezetimibe—Rash—Abacavir—acquired immunodeficiency syndrome	0.000128	0.000624	CcSEcCtD
Ezetimibe—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000128	0.000624	CcSEcCtD
Ezetimibe—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000623	CcSEcCtD
Ezetimibe—Headache—Abacavir—acquired immunodeficiency syndrome	0.000127	0.00062	CcSEcCtD
Ezetimibe—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000619	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000619	CcSEcCtD
Ezetimibe—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.000618	CcSEcCtD
Ezetimibe—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000618	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000126	0.00394	CbGpPWpGaD
Ezetimibe—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000614	CcSEcCtD
Ezetimibe—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000125	0.00161	CbGeAlD
Ezetimibe—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000611	CcSEcCtD
Ezetimibe—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00061	CcSEcCtD
Ezetimibe—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.00061	CcSEcCtD
Ezetimibe—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.00061	CcSEcCtD
Ezetimibe—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000607	CcSEcCtD
Ezetimibe—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000607	CcSEcCtD
Ezetimibe—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000606	CcSEcCtD
Ezetimibe—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000605	CcSEcCtD
Ezetimibe—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000605	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.0006	CcSEcCtD
Ezetimibe—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.000599	CcSEcCtD
Ezetimibe—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000598	CcSEcCtD
Ezetimibe—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000598	CcSEcCtD
Ezetimibe—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000122	0.000598	CcSEcCtD
Ezetimibe—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000597	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000595	CcSEcCtD
Ezetimibe—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000591	CcSEcCtD
Ezetimibe—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.00059	CcSEcCtD
Ezetimibe—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.00012	0.00155	CbGeAlD
Ezetimibe—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000588	CcSEcCtD
Ezetimibe—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000587	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000586	CcSEcCtD
Ezetimibe—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000585	CcSEcCtD
Ezetimibe—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000583	CcSEcCtD
Ezetimibe—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000583	CcSEcCtD
Ezetimibe—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000583	CcSEcCtD
Ezetimibe—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000581	CcSEcCtD
Ezetimibe—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000581	CcSEcCtD
Ezetimibe—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.00058	CcSEcCtD
Ezetimibe—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.00058	CcSEcCtD
Ezetimibe—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.000578	CcSEcCtD
Ezetimibe—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000575	CcSEcCtD
Ezetimibe—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000575	CcSEcCtD
Ezetimibe—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000568	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000568	CcSEcCtD
Ezetimibe—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000565	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000564	CcSEcCtD
Ezetimibe—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000564	CcSEcCtD
Ezetimibe—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000563	CcSEcCtD
Ezetimibe—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00056	CcSEcCtD
Ezetimibe—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00056	CcSEcCtD
Ezetimibe—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000559	CcSEcCtD
Ezetimibe—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000559	CcSEcCtD
Ezetimibe—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000556	CcSEcCtD
Ezetimibe—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000556	CcSEcCtD
Ezetimibe—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000555	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000555	CcSEcCtD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000113	0.00353	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000113	0.00353	CbGpPWpGaD
Ezetimibe—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000551	CcSEcCtD
Ezetimibe—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000551	CcSEcCtD
Ezetimibe—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.00055	CcSEcCtD
Ezetimibe—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000549	CcSEcCtD
Ezetimibe—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000547	CcSEcCtD
Ezetimibe—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000543	CcSEcCtD
Ezetimibe—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000542	CcSEcCtD
Ezetimibe—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000541	CcSEcCtD
Ezetimibe—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000539	CcSEcCtD
Ezetimibe—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000539	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000538	CcSEcCtD
Ezetimibe—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000537	CcSEcCtD
Ezetimibe—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000537	CcSEcCtD
Ezetimibe—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000537	CcSEcCtD
Ezetimibe—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000537	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000534	CcSEcCtD
Ezetimibe—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000533	CcSEcCtD
Ezetimibe—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000533	CcSEcCtD
Ezetimibe—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000527	CcSEcCtD
Ezetimibe—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000525	CcSEcCtD
Ezetimibe—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000519	CcSEcCtD
Ezetimibe—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000519	CcSEcCtD
Ezetimibe—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000519	CcSEcCtD
Ezetimibe—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000517	CcSEcCtD
Ezetimibe—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000517	CcSEcCtD
Ezetimibe—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000516	CcSEcCtD
Ezetimibe—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000514	CcSEcCtD
Ezetimibe—Rash—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000512	CcSEcCtD
Ezetimibe—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000512	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00051	CcSEcCtD
Ezetimibe—Headache—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000509	CcSEcCtD
Ezetimibe—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000507	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000103	0.00322	CbGpPWpGaD
Ezetimibe—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000502	CcSEcCtD
Ezetimibe—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.0005	CcSEcCtD
Ezetimibe—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000495	CcSEcCtD
Ezetimibe—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000493	CcSEcCtD
Ezetimibe—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000493	CcSEcCtD
Ezetimibe—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.98e-05	0.000488	CcSEcCtD
Ezetimibe—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.96e-05	0.000487	CcSEcCtD
Ezetimibe—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.93e-05	0.000486	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.9e-05	0.0031	CbGpPWpGaD
Ezetimibe—Rash—Efavirenz—acquired immunodeficiency syndrome	9.89e-05	0.000484	CcSEcCtD
Ezetimibe—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.88e-05	0.000483	CcSEcCtD
Ezetimibe—Nausea—Indinavir—acquired immunodeficiency syndrome	9.87e-05	0.000482	CcSEcCtD
Ezetimibe—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000481	CcSEcCtD
Ezetimibe—Headache—Efavirenz—acquired immunodeficiency syndrome	9.83e-05	0.000481	CcSEcCtD
Ezetimibe—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.82e-05	0.00048	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.78e-05	0.00306	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	9.78e-05	0.00306	CbGpPWpGaD
Ezetimibe—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000469	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.58e-05	0.003	CbGpPWpGaD
Ezetimibe—ABCB1—brain—acquired immunodeficiency syndrome	9.56e-05	0.00123	CbGeAlD
Ezetimibe—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.55e-05	0.000467	CcSEcCtD
Ezetimibe—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000465	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	9.48e-05	0.00296	CbGpPWpGaD
Ezetimibe—Rash—Delavirdine—acquired immunodeficiency syndrome	9.47e-05	0.000463	CcSEcCtD
Ezetimibe—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.46e-05	0.000463	CcSEcCtD
Ezetimibe—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.45e-05	0.000462	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.42e-05	0.00295	CbGpPWpGaD
Ezetimibe—Headache—Delavirdine—acquired immunodeficiency syndrome	9.41e-05	0.00046	CcSEcCtD
Ezetimibe—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.39e-05	0.000459	CcSEcCtD
Ezetimibe—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.32e-05	0.000456	CcSEcCtD
Ezetimibe—ABCB1—lymph node—acquired immunodeficiency syndrome	9.24e-05	0.00119	CbGeAlD
Ezetimibe—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.18e-05	0.000449	CcSEcCtD
Ezetimibe—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000447	CcSEcCtD
Ezetimibe—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	9.14e-05	0.000447	CcSEcCtD
Ezetimibe—Pruritus—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000441	CcSEcCtD
Ezetimibe—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.92e-05	0.000436	CcSEcCtD
Ezetimibe—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.000432	CcSEcCtD
Ezetimibe—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.83e-05	0.000432	CcSEcCtD
Ezetimibe—Rash—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.000428	CcSEcCtD
Ezetimibe—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.000428	CcSEcCtD
Ezetimibe—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.72e-05	0.000427	CcSEcCtD
Ezetimibe—Headache—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000425	CcSEcCtD
Ezetimibe—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.000416	CcSEcCtD
Ezetimibe—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.43e-05	0.000412	CcSEcCtD
Ezetimibe—Rash—Saquinavir—acquired immunodeficiency syndrome	8.43e-05	0.000412	CcSEcCtD
Ezetimibe—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.42e-05	0.000412	CcSEcCtD
Ezetimibe—Headache—Saquinavir—acquired immunodeficiency syndrome	8.37e-05	0.000409	CcSEcCtD
Ezetimibe—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.25e-05	0.000403	CcSEcCtD
Ezetimibe—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.000396	CcSEcCtD
Ezetimibe—Rash—Lamivudine—acquired immunodeficiency syndrome	8.04e-05	0.000393	CcSEcCtD
Ezetimibe—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.03e-05	0.000393	CcSEcCtD
Ezetimibe—Headache—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000391	CcSEcCtD
Ezetimibe—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.94e-05	0.000388	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—TAT—acquired immunodeficiency syndrome	7.93e-05	0.00248	CbGpPWpGaD
Ezetimibe—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.00037	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	7.41e-05	0.00232	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	7.41e-05	0.00232	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	7.21e-05	0.00225	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	7.05e-05	0.0022	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AGPS—acquired immunodeficiency syndrome	6.74e-05	0.00211	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TAT—acquired immunodeficiency syndrome	6.74e-05	0.00211	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TAT—acquired immunodeficiency syndrome	6.74e-05	0.00211	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ALB—acquired immunodeficiency syndrome	6.05e-05	0.00189	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AGPS—acquired immunodeficiency syndrome	5.73e-05	0.00179	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AGPS—acquired immunodeficiency syndrome	5.73e-05	0.00179	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	5.48e-05	0.00171	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TAT—acquired immunodeficiency syndrome	5.02e-05	0.00157	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.66e-05	0.00146	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TAT—acquired immunodeficiency syndrome	4.65e-05	0.00145	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ALB—acquired immunodeficiency syndrome	4.58e-05	0.00143	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ALB—acquired immunodeficiency syndrome	4.41e-05	0.00138	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.36e-05	0.00136	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.27e-05	0.00133	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AGPS—acquired immunodeficiency syndrome	3.95e-05	0.00124	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.87e-05	0.00121	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	3.68e-05	0.00115	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.82e-05	0.000882	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.64e-05	0.000826	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—acquired immunodeficiency syndrome	2.58e-05	0.000807	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.51e-05	0.000786	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.51e-05	0.000785	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.14e-05	0.000668	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.99e-05	0.000622	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.97e-05	0.000615	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.87e-05	0.000584	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.73e-05	0.000541	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.55e-05	0.000484	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.39e-05	0.000435	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—acquired immunodeficiency syndrome	1.38e-05	0.000432	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.32e-05	0.000412	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—acquired immunodeficiency syndrome	1.18e-05	0.000368	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—acquired immunodeficiency syndrome	1.18e-05	0.000368	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	9.55e-06	0.000299	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.36e-06	0.000293	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—acquired immunodeficiency syndrome	8.75e-06	0.000274	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—acquired immunodeficiency syndrome	8.11e-06	0.000253	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.38e-06	0.000137	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.7e-06	8.44e-05	CbGpPWpGaD
